The selective μ-OR antagonist CTAP and δ2-OR antagonist naltriben eliminated these protective effects of CCH, while the selective δ1-OR antagonist BNTX and κ-OR antagonist nor-binaltorphimine had no effect on the protective effects of CCH[59]. This evidence concerns the gene OPRK1 and columnar cell hyperplasia of the breast.